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The objective of this study was to examine hepatic steroid inactivation and luteal
function throughout bovine gestation. In pregnant beef cows, cytochrome P450 3A
activity decreased from mid- to late-gestation, while progesterone concentrations tended
to increase from mid- to late-gestation. Uridine diphosphate-glucuronosyltransferase
activity per kg of body weight was increased in pregnant vs non-pregnant dairy cows.
Total corpus luteum (CL) blood perfusion tended to be increased in pregnant vs nonpregnant dairy cows. Hepatic portal blood flow per kg of body weight was increased in
pregnant vs non-pregnant dairy cows. Hepatic steroid inactivating enzyme activity, CL
blood perfusion, and portal blood flow did not differ between pregnant and non-pregnant
beef cows. There was no difference in progesterone concentrations in pregnant vs nonpregnant dairy or beef cows. The current study highlights the relevance of further
investigation into steroid secretion and inactivation and their impact on the maintenance
of pregnancy in cattle.
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CHAPTER I
REVIEW OF LITERATURE

Steriodogenic action throughout gestation
Progesterone is required for the maintenance of pregnancy as it blocks uterine
contractions from occurring creating a quiescent uterine environment until parturition [1].
In cattle, removal of the corpus luteum, the main source of progesterone, will lead to
termination of pregnancy unless exogenous progesterone is provided [2]. This is due to
the fact that, unlike in most species, the bovine placenta does not become the dominant
progesterone source until near parturition (d 200 of gestation) and after removal of the
corpus luteum [3]. In ruminants, pregnancy wastage may be due to decreased
concentrations of progesterone [4].
In addition to preventing parturition, progesterone is also involved in placental
nutrient exchange as it stimulates glucose to be transported to the growing fetus [5] and
influences the secretion of nutrients and growth factors from the uterine endometrium [6].
Exogenous progesterone supplementation may or may not improve conception rates [7–
9]. In lactating dairy cows d 3.5 to d 10 post-insemination supplemented progesterone
increases pregnancy rates with 48% pregnancy rates in progesterone treated cows
compared to 35% in control animals [7]. However, other groups have found confounding
results showing no difference in conception rates between progesterone treated and
control groups [8] and decreases in conception rates of progesterone treated groups in
8

lactating dairy cattle [9]. It is important to note that these studies supplemented
progesterone at various time points post-insemination which could account for the
variation in results. Therefore, exogenous progesterone supplementation remains to be a
questionable reproductive management practice.
Throughout healthy gestation, uterine blood flow increases by as much as 50-fold
in order to supply the fetus and placenta with sufficient nutrients and oxygen for normal
growth and development [10]. The role of estrogen in increasing uterine blood flow is
well established in both in vitro and in vivo models [10]. Estrogen, as well as estrogen
receptors (ERs), ER-α and ER-β, are in part responsible for the short- and long- term
adaptations in the uterine endothelium throughout gestation. Estrogen receptor knock-out
models have shown a dependence on ER-α for normal embryonic implantation [11].
Gestational rises in uterine blood flow are greatly mediated by up-regulation of gene
transcription and the expression of endothelial nitric oxide synthase and thus increasing
endothelial production of nitric oxide, a potent vasodilator [12].
The effect of estradiol supplementation during synchronization on pregnancy
rates has also been examined with varying results. Sellars et al [13] found that although
estradiol supplementation during estrus synchronization of lactating dairy cattle resulted
in a transient increase in peripheral estradiol concentrations, there was no effect on
pregnancy rates in estradiol treated cows versus control cows. In contrast, Cerri et al [14]
found that supplementation of estradiol during synchronization increased conception at
first insemination, postpartum. Thus, exogenous estrogen as a practical reproductive
management practice has yet to be verified.

9

Compromised pregnancies can result in altered steroid concentrations. Increased
dietary intake in sheep during mid- to late-pregnancy can decrease peripheral
concentrations of progesterone and estradiol-17β [15]. Similarly, Redmer et al [16] has
shown that overnourished adolescent sheep had decreased maternal progesterone
concentrations at d 90 and d 130 of gestation. Apart from peripheral concentrations of
steroids, sheep fed at 0.5 times maintenance requirements had decreases estrogen
receptor and progesterone receptor mRNA expression in oviduct tissues compared to
controls fed at 1.5 times maintenance requirements [17].
Steroid biosynthesis
Steroid hormones are produced in various tissues of the body such as the adrenal
cortex, testis, and ovary. In post-pubertal non-pregnant females, progesterone is mainly
produced in the luteal cells of the corpus luteum while the main source of estrogen is the
developing ovarian follicle. Steroid hormones are derived from cholesterol and share the
same basic ring structure, three six-carbon rings and a single five-carbon ring, known as
the cyclopentanoperhydrophenanthrene nucleus. Steroid structure varies only in the side
chains attached to the base ring structure and the location of double-bonds within the
rings. Steroid hormones are non-polar and lipid-soluble and can thus freely diffuse across
lipid bi-layer membranes of cells. Steroid biosynthesis occurs in the mitochondria of
steroidogenic cells. The rate-limiting step of steroid formation is the transfer of
cholesterol from the outer mitochondrial membrane to the inner mitochondrial membrane
[18]. In order for this to occur, free cholesterol must accumulate at the outer
mitochondrial membrane and then be transferred to the inner membrane [18]. Free
cholesterol accumulates within the cell through the breakdown of low density lipoprotein
10

into esterified cholesterol and free cholesterol [18]. Steriodogenic acute regulatory
proteins are the major intracellular components responsible for the transfer of cholesterol
from the outer mitochondrial membrane to the inner mitochondrial membrane [18]. Once
cholesterol reaches the inner mitochondrial membrane, cytochrome P450 cholesterol side
chain cleavage enzyme (CYP11A1) catalyzes the conversion of cholesterol to
pregnenolone [19]. Pregnenolone then exits the mitochondria and enters the microsomal
compartment where it is converted to progesterone via 3 β-hydroxysteriod dehydrogenase
[18]. Progesterone is then secreted from the tissue or converted to a variety of other
steroids specific to the steroidogenic tissue [18]. Once steroid production is complete, the
non-polar lipid-soluble structure allows for passive diffusion out of the cell.
It is important to note that both production from the corpus luteum and/or hepatic
steroid inactivation of progesterone impacts its peripheral concentrations. Rhinehart et al
[20] examined the relationship between luteal progesterone secretion and hepatic
clearance in pregnant lactating dairy cattle. Cows were classified as having either “high”
(> 4.0 ng/mL) or “low” (< 2.5 ng/mL) concentrations of progesterone. These cows were
then lutectomized and placed on equal exogenous progesterone therapy. Luteal tissue was
also cultured to examine progesterone secretion. Progesterone concentrations in “high”
and “low” cows diverged after 40 h of exogenous progesterone therapy. Biosynthesis of
progesterone by cultured luteal tissue did not differ between “high” and “low” cows
showing that hepatic catabolism was a major contributor to modulating peripheral
progesterone concentrations.
The corpus luteum (CL) is formed from the ovulatory follicle. During ovulation,
as the walls of the follicle collapse, thecal and granulosal cells are intermingled together.
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Thecal cells will become small luteal cells while granulosal cells will become large luteal
cells, both of which are steroidogenic. This transformation from thecal and granulosal
cells into luteal cells is known as lutenization. A wide variety of cell types make up the
bovine CL with endothelial cells and pericytes representing approximately 50% of all
cells in the mature CL [21]. In order for adequate progesterone production, appropriate
vascular adaptations to the CL must occur [22]. Several angiogenic factors, such as
vascular endothelial growth factor, fibroblast growth factor, and insulin-like growth
factor, are involved in these vascular adaptations [22].
Luteal size has long been used as an appropriate estimator for luteal function due
to the high positive correlation between luteal size and progesterone concentrations [23].
However, Herzog et al [24] found the use of CL blood perfusion as a more efficient
indicator of luteal function over luteal size. In lactating dairy cattle, blood perfusion of
the CL was positively correlated with progesterone during the growth, static, and
regression phases of the CL whereas luteal size was only positively correlated with
progesterone during the growth and regression phases [24].
While it is true that the placenta of all eutherian mammals is capable of producing
progesterone, special circumstances must occur for the bovine placenta to secrete
substantial amounts of progesterone [3]. Conley and Ford [3] conducted a study
investigating placental progesterone production in beef cattle at 200 d of gestation. The
caruncular artery and caruncular vein of a single placentome was catheterized. Cows
were then assigned to one of two treatment groups, a control group receiving an vehicle
injection, and a treatment group receiving 25 mg of PGF2α in order to regress the CL.
Blood samples were then collected from the caruncular arteries and veins to compare
12

progesterone production between the two groups. Arteriovenous progesterone
concentrations difference was negative in control cows (-2.13 ng/mL) and positive in
PGF2α-treated cows (+1.36 ng/mL). In the last third of bovine gestation, PGF2α will fail
to terminate the pregnancy due to placental progesterone production [3]. However, the
placenta will only produce significant concentrations of progesterone if the influence of
the CL is removed [3]. The CL may exert control over placental steroidogenesis through
negative feedback of progesterone on its synthesis from the placenta [3].
Metabolic clearance
Steroids are highly lipophilic and therefore difficult for animals to excrete through
the urine and feces. Several hepatic enzymes contribute to steroid inactivation by adding
polar groups to the steroid nucleus. These enzymes include cytochrome P450 1A
(CYP1A), 2C (CYP2C), 3A (CYP3A), aldo-keto reductase 1C (AKR1C), and uridine
diphosphate-glucuronosyltransferase (UGT, [25–27]).
Steroids undergo both phase I and phase II biotransformation. Biotransformation
can be defined as a process by which a steroid is converted to its less-active metabolites.
Phase I progesterone biotransformation consists of the addition of a hydroxyl group via
CYP2C, CYP3A, and AKR1C to the 6β, 21, 3α, or 20α positions of the progesterone
molecule resulting in hydroxyprogesterone metabolites [25, 28, 29]. Phase II
biotransformation of progesterone involves UGT enzymes conjugating the
hydroxyprogesterone metabolite with glucuronic acid [26]. A potential pathway of
progesterone biotransformation is illustrated in Figure 1. Cellular 17β-hydroxysteroid
dehydrogenase type 1 and 2 are involved in estrogen metabolism via the conversion of
estradiol-17β to estrone. Estradiol-17β and estrone serve as substrates for P45013

dependent hydroxylases which then generate a series of intermediate metabolites [30].
The major metabolites include 2- and 4-OH-estrogens which are biologically active
towards uterine angiogenesis during pregnancy [31]. These metabolites will then undergo
one of two possible transformation routes, further conversion to 2- and 4-methoxy
metabolites by catechol-O-methyltransferase or glucoronidation by UGTs. The 2- and 4methoxy metabolites can also be converted via UGTs and have cardiovascular benefits
[32]. A major pathway for estradiol biotransformation is diagramed in Figure 2. Aside
from rodent characterization studies, there is limited information on steroid inactivation
pathways in livestock species.
Pregnancy influences cytochrome P450 (CYP) enzyme activity in human, mice,
and rats [33–35]. In general, cytochrome P450 2A6 (CYP2A6), 3A4 (CYP3A4), and 2C9
(CYP2C9) activities are increased, whereas CYP1A2 and CYP2C19 mediated
metabolism is decreased during human pregnancy [33]. In contrast, hepatic protein
expression and activity of CYP enzymes were consistently decreased in pregnant versus
non-pregnant rats of similar age [36, 37]. He et al [34] examined hepatic gene expression
profiles in pregnant and lactating rats compared to virgin controls and found that gene
expression of drug-metabolizing enzymes and nuclear receptors were decreased in
pregnant and lactating rats compared to virgin controls. Similarly, pregnancy typically
decreases P450 expression and activity in mice, which was strongly correlated with
peroxisome proliferator-activated receptor alpha (PPARα, [35]). Apart from xenobiotic
metabolism, P450 enzymes are involved in a number of pathways including endogenous
vitamin D3 activation, metabolism of cholesterol to bile acids, inactivation of toxins, and
metabolism of all major classes of steroid hormones [33, 38]. Currently, these enzymes
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have not been characterized throughout bovine gestation and little is known about how
hepatic enzyme function may contribute to reproductive performance via substrate
bioavailability.
As mentioned, the majority of P450 enzymes examined are down-regulated
during pregnancy in the mouse, which was highly correlated with hepatic PPARα
expression [35]. Hepatic PPARs function as regulators of mammalian metabolism with
PPARα promoting fatty acid oxidation under fasting conditions. Induction of PPARα is
also speculated to decrease pro-atherosclerotic proteins and mice lacking PPARα have
prolonged inflammatory response, thus indicating that PPARα has anti-inflammatory
action [39]. There is a 50% decrease in CYP3A expression in a PPARα gene knockout
model in primary human hepatocytes [40]. Concentrations of estradiol are a potent
regulator of PPARα mRNA and protein expression in rats [41]. The interspecies
differences in P450 expression and modulation have been previously reported, whereby
substrate conjugation and metabolism varied substantially across pig, cattle, goat, and
sheep [42]. Therefore, steroid and xenobiotic metabolism in cattle cannot be extrapolated
from previous studies in human, pig, or rodent species.
Altering metabolic clearance
Cattle with increased dry matter intake have increased blood flow to the digestive
tract and liver. This in turn leads to an increased delivery rate of steroids to the liver and
thus increased metabolism of these substrates [43]. Increasing dry matter intake also
increases liver blood flow and liver oxygen consumption in sheep [44] and increases
blood flow to the hepatic portal vein in sows [45]. There is a significant linear
relationship between intake of metabolizable energy and liver blood flow in cattle of
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various sizes and physiological conditions [46]. However, lactating cows have roughly
double the basal liver blood flow of non-lactating cows which can be attributed to the
chronic effects of the high plane of nutrition required by lactating cows. This continuous
high plane of nutrition is what appears to chronically elevate liver blood flow and
metabolic clearance rate of estradiol and progesterone leading to decreased reproductive
efficiency [47]. Excessive hepatic steroid inactivation contributes to decreased peripheral
concentrations, which can alter reproductive performance. Two potential changes that
occur during mid- to late-gestation are decreased placental nutrient exchange due to
decreased concentrations of progesterone [5] and decreased uterine blood flow due to
decreased concentrations of estrogen [48].
Several methods exist for measuring portal blood flow including: dye-dilution,
ultrasonic flow probes, bromosulphthalein infusion, and Doppler ultrasonography. The
dye-dilution method involves the continuous infusion of a dye, often para-aminohippuric
acid, at a constant rate into an artery upstream of the portal vein. Blood samples are then
taken from portal vein and the dilution of para-aminohippuric acid is used to calculate
blood flow [49]. This method is perhaps the most invasive as two vessels must be
catheterized. Utilizing ultrasonic flow probes is an invasive technique for measuring
blood flow as the probe must be placed around and sutured to the vessel of interest. As
described by the manufacturer (Transonic Systems Inc., Ithica, NY) these probes measure
blood flow by emitting ultrasound waves between two transducers. The time it takes for
the ultrasound wave to travel from one transducer to the other is measured as the transit
time. The difference in transit time between the upstream and downstream signals is
volume flow. This method involves invasive surgery to locate and apply the probe to the
16

vessel of interest. Another downfall of this method is that growing vessels can become
constricted resulting in more surgeries to replace the flow probe with a larger model as
the vessel increases in diameter. Bromosulphthalein infusion is a less invasive method of
measuring blood flow. Bromosulphthalein dye is exclusively cleared by the liver.
Therefore it is infused at a constant rate into the jugular vein while concurrent blood
samples from the opposite jugular vein are collected. These blood samples are then
evaluated for concentration of bromosulphthalein, which is used to calculate the
bromosulphthalein clearance rate (clearance rate of bromosulphthalein (L/h) = infusion
rate (μg/h)/bromosulphthalein concentration (μg/l) in jugular serum or plasma) [47, 50].
This rate of clearance is equivalent to liver blood flow, which is an estimate of total liver
blood flow, including the portal vein and hepatic artery [47, 50]. Portal blood flow
accounts for ~80% of total liver blood flow with hepatic artery blood flow accounting for
the remaining ~20% [51]. Therefore, portal blood flow can be estimated from total liver
blood flow, and vice versa. The bromosulphthalein infusion method is seemingly the least
invasive of the previously discussed methods, only requiring catheterization of the
jugulars. However, it still subjects the animal to a certain degree of stress. Doppler
ultrasonography is perhaps the only non-invasive technique for measuring portal blood
flow and is therefore the least stressful method to the animals. Ultrasonography also does
not require a withdrawal period that dye-dilution and bromosulphthalein infusion
techniques would, thus decreasing wastage of milk in lactating animals. This novel
approach to measuring blood flow will be described further. Various sources and
methods of measuring portal blood flow and total liver blood flow are shown in Table 1.
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Many in vitro and in vivo studies have been conducted in attempts to alter steroid
catabolism. Lemley et al [52] conducted a study in which mice hepatocytes were cultured
with varying concentrations of insulin (0.1, 1, or 10 nM) or glucagon (0.01, 0.1 or 1 nM)
and a set concentration of progesterone (5 ng/mL). After incubating for 4 h, hepatocytes
treated with insulin had a dose-dependent decrease in CYP2C and CYP3A activity [52].
An increase in progesterone concentration was also observed in hepatocytes treated with
0.1 or 10 nM of insulin compared to controls (0 nM insulin) [52]. Glucagon treatment
had no such effect on enzyme activity or progesterone concentrations [52]. Results of in
vivo studies in sheep and cattle corroborate these data. Ovariectomized ewes fed sodium
propionate, a gluconeogenic substrate, had a 45% decrease in CYP activity (CYP2C and
CYP3A) compared to ovariectomized ewes fed sodium acetate, a non-gluconeogenic
substrate [53]. However, there was no difference in progesterone clearance between these
treatment groups [53]. Lactating Holstein cows fed a high cornstarch diet to induce
increased insulin concentrations had an approximately 50% decreased CYP2C and
CYP3A activity compared to cows fed a high fiber diet or non-insulin stimulating diet
[50]. The half-life of progesterone was also increased in cows fed a high cornstarch diet
versus cows fed a high fiber diet without any changes in liver blood flow [50]. These
studies demonstrate that progesterone catabolism can be altered without compromising
dry matter intake, liver blood flow, or nutritional value of the diet.
Ultrasonography
Diagnostic ultrasonography utilizes piezoelectric crystals activated by alternating
polarity of an electric charge. As a result of this alternating polarity, the crystals expand
and contract thus emitting ultrasound waves. The piezoelectric property of the crystals
18

allows them to generate ultrasound waves and generate an electric signal when struck by
returning ultrasound waves. When these waves strike an object or tissue, majority of the
pulse continues through the tissue; the remainder is reflected back to the now quiescent
crystals. This once again causes the crystals to expand and contract producing a small
voltage that is transmitted to a receiver. The delay between wave emission and echo
reception allows for the determination of distance between the crystals and the object or
tissue. This also allows for the spatial relationship between the crystals and the object or
tissue to be depicted on the ultrasound screen [54].
Doppler ultrasonography
Doppler ultrasonography uses the principles of the Doppler effect for measuring
blood flow through a vessel. The Doppler effect is a phenomenon described as the change
in frequency of a wave when the source of the wave is moving with respect to an
observer or vice versa. This causes an increase in frequency as the wave source and the
observer become closer in distance and a decrease in frequency as they become farther
apart. It is this phenomenon that allows ultrasonongraphy to be used for measuring blood
flow. Blood is a suspension of erythrocytes, leukocytes, and thrombocytes in liquid
plasma. When measuring blood flow using Doppler ultrasonography, the ultrasound
transducer is stationary and the moving reflectors that return ultrasound echoes are
erythrocytes within the vessel. The width of an erythrocyte is much narrower than the
ultrasound transducer, thus erythrocytes are diffuse reflectors. Diffuse reflectors reflect
ultrasound echoes in many directions. The small portion of echoes that are reflected
towards the transducer is termed backscatter. The backscatter from a single erythrocyte is
extremely low, however, many scatters are received at one time and thus adequate energy
19

is provided to activate the piezoelectric crystals in the transducer. The angle at which the
ultrasound beam interacts with the blood vessel, or angle of insonation, is important to
consider for accurate blood flow measurements. At 90°, with blood traveling
perpendicular to the transducer, there is no detectable Doppler shift, and thus no flow is
detected. With smaller angles of insonation there is less variability in blood flow
measurements [54].
Power-flow imaging
Power Doppler is more sensitive to decreased or weak blood flow than
conventional color Doppler sonography. This increase in sensitivity makes power-flow a
more accurate method for measuring vessels with small diameter thus making it an
efficient tool for measuring tissue perfusion. Unlike conventional Doppler
ultrasonography, the power-flow option is independent of the angle of insonation as
velocity is not being directly measured. Power-flow, instead, estimates the strength of the
Doppler signal and displays color pixels relative to the signal strength. The power-flow
color bar ranges from dark red (lowest intensity) to yellow (highest intensity, [54]).
Implications
Further characterization of hepatic steroid inactivating enzymes during gestation
may allow researchers to design specific therapeutic supplements to modulate steroid
metabolism during gestation. Modifying the clearance rate of progesterone or estradiol
could lead to an increase in placental nutrient transfer capacity and/or uterine blood flow
during specific time points of gestation. The ability to modulate these enzymes in order to
increase peripheral concentrations of progesterone could decrease pregnancy wastage and
20

thus increase reproductive efficiency and production. The vascular adaptations of the
uterus throughout pregnancy may be modulated by estradiol metabolites, 2-OH-estradiol
and 4-OH-estradiol, that remain biologically active after the hydroxylation of estradiol by
CYP1A and CYP3A. These metabolites are involved in angiogenic regulation during
pregnancy. In addition, mice showing a deficiency in these metabolites exhibit clinical
signs of preeclampsia such as hypertension and decreased angiogenesis [31]. Thus a
decrease in P450 enzyme activity could result in decreased concentrations of these
biologically active estradiol metabolites and in turn decrease uterine vascular
proliferation during pregnancy.
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Table 1

Average total liver blood flow and hepatic portal blood flow from various
sources and methods.

Abbreviations: PAH = para-aminohippuric acid; BSP = bromosulphthalein dye.
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Figure 1

Progesterone inactivation in hepatocytes

Phase I enzymes add hydroxyl groups to various locations on the steroid nucleus. Phase II
enzymes conjugate the hydroxyprogesterone metabolite with glucoronic acid. Abbreviations:
CYP2C = cytochrome P450 2C; CYP3A = cytochrome P450 3A; AKR1C = aldo-keto reductase
1C subfamily; UGT1A = uridine diphosphate-glucuronosyltransferase 1A; UGT1B = uridine
diphosphate-glucuronosyltransferase 1B. Figure adapted from [27].
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Estrogen inactivation in hepatocytes

Estrodiol and estrone serve as substrates for hydroxylation by CYP1A and CYP3A. These hydroxy metabolites then undergo one of two
pathways, further conversion by COMT or glucuronidation by UGTs. Methoxy metabolites produced by COMT can also undergo
glucoronidation by UGTs. Abbreviations: 17bHSD = 17-beta-hydroxysteroid dehydrogenase; CYP1A = cytochrome P450 1A; CYP3A =
cytochrome P450 3A; UGT = uridine diphosphate-glucuronosyltransferase; COMT = catechol-O-methyltransferase. Figure adapted from [32].

Figure 2
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CHAPTER II
HEPATIC STEROID METABOLIZING ENZYME ACTIVITY DURING EARLY,
MID, AND LATE BOVINE PREGNANCY

Reprinted with permission of Elsevier from Domestic Animal Endocrinology 49
(2014) 31–38.
Introduction
Pregnancy is known to influence xenobiotic metabolism via alterations in
expression and activity of cytochrome P450 (P450) enzymes [1,2]. Hepatic protein
expression and activity of P450s are consistently lower in pregnant versus non-pregnant
rats of similar age [3,4]. Similarly, pregnancy typically decreases P450 expression and
activity in mice, which is strongly correlated with peroxisome proliferator-activated
receptor alpha (PPARα) [2]. In addition to xenobiotic metabolism, P450 enzymes are
involved in a number of pathways including endogenous vitamin D3 activation,
metabolism of cholesterol to bile acids, and metabolism of all major classes of steroid
hormones [5]. Apart from characterization studies in rodents, limited studies have
examined hepatic activity of P450s in pregnant livestock species, which could have direct
implications in modulating peripheral concentrations of endogenous hormones.
Progesterone (P4) is required for the maintenance of pregnancy as it blocks
uterine contractions from occurring creating a quiescent uterine environment until
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parturition [6-8]. In ruminants, pregnancy loss may be due to decreased concentrations of
P4 [9]. It is important to note that both production from the corpus luteum and/or hepatic
steroid inactivation impacts peripheral concentrations of P4 [10]. Cattle with an elevated
dry matter intake have increased blood flow to the digestive tract and liver. This in turn
leads to an increased delivery rate of steroids to the liver and thus increases metabolism
of these substrates [11]. Excessive hepatic steroid inactivation contributes to decreased
peripheral concentrations, which can alter reproductive performance. Previous studies
have observed a decrease in peripheral concentrations of P4 and estradiol-17β (E2) in
mid- to late-pregnant ewes fed 140% of nutrient requirements versus control [12]. In
contrast, peripheral concentrations of P4 and E2 were increased in ewes nutrient
restricted from mid- to late-gestation [12]. This variation in steroid bioavailability during
mid- to late-gestation could alter placental nutrient exchange or uterine blood flow, which
are partially controlled by P4 [13] or E2 [14], respectively.
Steroids are highly lipophilic and therefore difficult for animals to excrete through
the urine and feces. Several hepatic enzymes contribute to steroid inactivation by adding
polar groups to the cyclopentanoperhydrophenanthrene nucleus. These enzymes include
cytochrome P450 1A (CYP1A), 2C (CYP2C), 3A (CYP3A), aldo-keto reductase 1C
(AKR1C), and uridine diphosphate-glucuronosyltransferase (UGT) [15–17]. Currently,
these enzymes have not been characterized throughout bovine gestation and little is
known about how hepatic enzyme function may contribute to reproductive performance
via substrate bioavailability. Moreover, a paucity of information exists on bovine hepatic
transcription factors that may regulate steroid metabolic enzymes during gestation.
Therefore, our primary objective was to characterize hepatic steroid inactivating enzymes
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throughout gestation as well as the hepatic transcription factor PPARα. In addition, we
also examined the effect of maternal nutrient restriction followed by realimentation at
different stages of gestation on hepatic steroid inactivating enzymes. We hypothesized
that maternal nutrient restriction would decrease hepatic steroid inactivating enzyme
activity and increase peripheral concentrations of P4 and E2. Moreover, a shorter
duration of realimentation following nutrient restriction would result in increased
concentrations of P4 and E2 during mid- to late-gestation.
Materials and methods
Animals, diets, and breeding
Animal care and use was approved by the North Dakota State University Animal
Care and Use Committee. Animal management, breeding, and experimental design were
previously published [18]. Briefly, multiparous crossbred beef cows (initial BW = 620.5
± 11.3 kg and BCS = 5.1 ± 0.1) predominately of Angus breeding were synchronized
using Select Synch plus P4 insert and fixed-time artificial insemination. On day 27 and
28 post-insemination, pregnancy was confirmed via transrectal ultrasonography (500SSV; Aloka, Tokyo, Japan) using a linear transducer probe (5 MHz). Non-pregnant cows
restarted the same breeding protocol; cows were allowed to be artificial inseminated only
twice during the experiment. On day 30 of gestation, cows were randomly assigned to
dietary treatments (Fig. 3): control (CON; 100% NRC; n = 18) and nutrient restriction
(RES; 60% NRC; n= 34). On day 85 cows were slaughtered (CON, n = 6 and RES, n =
6), remained on control (CC; n = 12) and restricted (RR; n = 12) treatments, or were
realimented to control (RC; n =11). On day 140 cows were slaughtered (CC, n = 6; RR, n
= 6; RC, n = 5), remained on control (CCC, n = 6; RCC, n = 5), or were realimented to
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control (RRC, n = 6). On day 254 all remaining cows were slaughtered (CCC, n = 6;
RCC, n = 5; RRC, n = 6).
Diet composition and nutrient analysis were previously published [18]. Briefly,
the control diet consisted of grass hay fed to meet 100% net energy recommendations for
maintenance and fetal growth [19] and to meet or exceed metabolizable protein, mineral,
and vitamin recommendations. Nutrient analysis determined the grass hay to consist of
11.8% Ash, 8.1% crude protein, 69.2% neutral detergent fiber, and 41.5% acidic
detergent fiber on a dry matter basis. Nutrient restricted cows received 60% of the same
control hay diet. Cows were individually fed once daily in a Calan gate system and had
ad libitum access to water. Vitamin and mineral supplement was top-dressed 3 times per
week at a rate of 0.18% of hay dry matter intake to meet or exceed vitamin and mineral
requirements relative to dietary net energy intake [19]. The vitamin and mineral
supplement (Trouw Dairy VTM with Optimins; Trouw Nutrition International, Highland,
IL, USA) consisted of 10% Ca, 5% Mg, 5% K, 2.7% Mn, 2.7% Zn, 1,565,610 IU/kg
vitamin A, 158,371 IU/kg vitamin D3, and 2,715 IU/kg vitamin E.
Liver collection and processing
At slaughter, maternal liver was removed, weighed, and approximately 5 g of
maternal liver was snap-frozen in supercooled isopentane (submerged in liquid nitrogen)
and stored at -80°C. Approximately 100 mg of liver tissue was weighed out, submerged
in 2 mL of potassium phosphate (KPO4) buffer (400 mM; pH = 7.4), and placed on ice
for the remainder of the procedure. Samples were then homogenized using a glass
Dounce homogenizer. The liver homogenate was centrifuged at 10,000 x g for 10 min at
4°C. The supernatant (S9 fraction) was then aliquoted into 5 separate tubes to prevent
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additional freeze thaw cycles between the enzymatic activity assays. Supernatant
fractions were stored at -80°C. Protein concentrations in the S9 fractions were determined
using a Coomassie Plus (Bradford) protein assay following the manufacturer’s protocol
(Thermo Scientific, Rockford, IL, USA). Enzyme activity is expressed relative to
maternal liver protein (RLU/min/mg of protein) and relative to maternal liver weight
(RLU/min/liver).
Cytochrome P450 activity assays
The CYP1A, CYP2C, and CYP3A assay kits and NADPH regeneration system
were purchased from Promega Corporation (Madison, WI, USA). Following
manufacturer’s instructions, reconstitution buffer was added to luciferin detection
reagent. The luciferin CEE (CYP1A), luciferin H (CYP2C), or luciferin IPA (CYP3A)
substrates were diluted in KPO4 buffer. The NADPH regeneration system was prepared
according to the manufacturer’s recommendations. In duplicate, the S9 liver fraction and
enzyme specific luciferin substrates were added to 96-well opaque white plates and preincubated for 10 min (CYP1A and CYP3A) or 30 min (CYP2C) at 37°C. After preincubation, enzyme reactions were initiated by adding the NADPH regeneration solution
to each well. The plate was incubated for an additional 30 min (CYP1A and CYP2C) or
10 min (CYP3A) at 37°C. Following this incubation the luciferin detection reagent was
then added to each well and the plate was protected from light and incubated at room
temperature for 20 min. All plates were then read using a Promega Multi-Plus plate
reader (Madison, WI, USA) using luminescence detection mode. Cytochrome P450
assays were validated with serially diluted S9 fractions. A linear relationship was
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determined between the rate of luminescence in relative light units (RLU) versus the
concentration of hepatic protein.
Aldo-keto reductase 1C
Aldo-keto reductase 1C activity was determined using the methods of Lemley and
Wilson [17]. Briefly, AKR1C was determined in S9 fractions using the specific substrate,
1-acenapthenol (Pfaltz & Bauer, Waterbury, CT, USA). Enzymatic reactions contained
150 μg of cytoplasmic protein, 250 μM 1-acenapthenol, and 500 μM NADP. The 1acenapthenol dependent reduction of NADP was standardized using the amount of
cytoplasmic protein. The reduction of NADP was determined by measuring the amount
of light absorbed at 340 nm for 10 min using a Spectra Max Plus plate reader (Sunnyvale,
CA, USA). The extinction coefficient for NADPH (6,220 L/ mol x cm) was used to
calculate the rate of reduced NADP in pmol per min per mg of protein. In addition, total
AKR1C activity in the liver was determined by calculating activity per g of liver and
multiplying by maternal liver weight.
Uridine 5’-diphospho-glucuronosyltransferase
The UGT assay kit was purchased from Promega Corporation (Madison, WI,
USA). The assay was performed following the manufacturer’s recommendations. During
the validation of this assay kit with hepatic bovine samples we observed maximal enzyme
activity, including complete disappearance of the substrate following the recommended
60 min incubation. Therefore, a separate experiment was performed to determine ideal
dilution of bovine liver homogenates and substrate incubation times. Briefly, a dilution
series of S9 fraction liver homogenates were incubated with substrate at different
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incubation intervals (10, 20, and 30 min). It was determined that a 10 min pre-incubation
resulted in an approximate 50% disappearance of the luminogenic substrate, therefore the
assay was modified by decreasing the incubation time compared to the manufacturer’s
recommendations. Uridine diphosphoglucoronic acid (UDPGA) was added to half of the
wells of a 96-well opaque white plate to serve as reaction wells while double distilled
water was added to the remaining wells to serve as control wells. The UGT reaction
mixture containing UGT multienzyme substrate that is consumed by UGT1A1, 1A8,
1A9, 1A10, 2B7, and 2B15 isozymes was then added to all wells. In duplicate, the S9
liver fraction was then added to the plate. The plate was then pre-incubated for 10 min at
37°C.The detection reagent was then added to each well and the plate was then protected
from light and incubated for 20 min at room temperature. The plate was then read using a
Promega Multi-Plus plate reader using luminescence detection mode. Activity of UGT
was calculated by subtracting the RLU in duplicate samples of reaction wells and control
wells.
Nuclear extraction
Preparation of hepatic nuclear extracts was conducted using a Nuclear Extraction
Kit purchased from Cayman Chemical Company (Ann Arbor, MI, USA) and performed
according to manufacturer’s recommendations for isolation of the nuclear fraction.
Briefly, 0.3 g of minced liver tissue was homogenized in 1 mL of homogenate buffer
solution consisting of nuclear extraction phosphate buffered saline, and phosphatase
inhibitors. This homogenate solution was then incubated on ice for 15 min and
centrifuged at 300 x g for 10 min at 4°C. The supernatant containing the cytoplasmic
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fraction was then discarded. Cellular pellets were then suspended in pre-chilled hypotonic
buffer solution consisting of nuclear extraction hypotonic buffer, phosphatase inhibitor,
and protease inhibitor and incubated on ice for 15 min. A detergent, 10% Nonidet P-40,
was then added and the solution was centrifuged at 14,000 x g for 30 sec at 4°C. The
supernatant was then discarded and the pellet was suspended in extractant buffer
consisting of nuclear extraction buffer, phosphotase inhibitor, and protease inhibitor, and
dithiothreitol. The solution was then vortexed, incubated on ice for 10 min, and
centrifuged at 14,000 x g for 10 min at 4°C; this cycle was repeated 6 times. The
supernatant containing the nuclear fraction was then placed in tubes and frozen at -80°C
for later analysis.
Peroxisome proliferator-activated receptor alpha
An enzyme-linked immunosorbent assay (ELISA) was used to determine PPARα
concentrations in the nuclear extracts. The PPARα transcription factor assay kit was
purchased from Cayman Chemical Company (Ann Arbor, MI, USA) and performed
following manufacturers’ recommendations. Briefly, 10 μL of sample nuclear extract and
90 μL of complete transcription factor binding assay buffer (CTFB) were added to the
appropriate wells. In addition, a positive control and a transcription factor PPAR
competitor dsDNA with unknown sample nuclear extract was included in each plate setup. The plate was then covered and incubated overnight at 4°C. The wells were then
emptied and washed 5 times with wash buffer containing Polysorbate 20. Transcription
factor PPARα primary antibody was added to each well excluding blank wells and
incubated for 1 h at room temperature, followed by transcription factor goat anti-rabbit
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HRP conjugated secondary antibody incubation for 1 h at room temperature.
Transcription factor developing solution was added to each well and the plate was
protected from light and incubated at room temperature for 30 min with gentle agitation.
Stop solution was then added to each well and absorbance measured at 450 nm using a
Spectra Max Plus plate reader (Sunnyvale, CA, USA) within 5 min of adding the stop
solution. Data are reported as absorbance units (AU) per mg of protein or per liver.
Steroid radioimmunoassay
The P4 radioimmunoassay was performed following manufacturers’ instructions
(Siemens Healthcare Diagnostics Inc., Los Angeles, CA, USA). Briefly, standards and
unknowns were added in duplicate to the antibody coated tubes provided with the kit.
Next, 1 mL of P4 tracer was added to all tubes then covered with parafilm, vortexed and
incubated at room temperature for 3 h. The liquid was then aspirated and discarded. The
tubes were then read in a Packard gamma counter (Meriden, CT, USA). The intra-assay
coefficient of variation for the P4 assay was 3.92%.
The E2 radioimmunoassay was performed following manufacturers’ instructions
(Siemens Healthcare Diagnostics Inc., Los Angeles, CA, USA) except that 500 μL of
serum was placed in the tubes instead of the recommended 100 μL. Briefly, standards and
unknowns were added in duplicate to the antibody coated tubes provided in the kit. Next
1 mL of E2 tracer was added to all tubes then covered with parafilm, vortexed and
incubated at room temperature for 3 h. The liquid was then aspirated and discarded. The
tubes were then read in a Packard gamma counter (Meriden, CT, USA). The intra-assay
coefficient of variation for the E2 assay was 3.67%.
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Statistical analysis
The MIXED procedure of SAS (SAS Inst. Inc., Cary, NC, USA) was used to test
the effect of gestational day within the control groups (CON, CC, CCC) only. The main
effect of maternal nutrient restriction was tested using a 2 × 2 factorial design comparing
CON, RES, CC, and RR treatment groups. Main effect of gestational day (85 versus 140)
and maternal nutrient restriction are discussed in the absence of significant gestational
day by dietary treatment interactions. The main effect of realimentation was tested using
a 2 × 2 factorial design comparing RC, RR, RCC, and RRC treatment groups. Main effect
of gestational day (140 versus 254) and duration of realimentation are discussed in the
absence of significant gestational day by dietary treatment interactions. Data found to be
non-normally distributed were tested using the Wilcoxon rank sum test. Treatment means
were separated using the PDIFF options of the LSMEANS statement. Pearson correlation
coefficients were determined using the CORR procedure of SAS. Least square means and
SE are reported. Statistical significance was declared at P ≤ 0.05. Tendencies were
discussed when P > 0.05 but ≤ 0.10.
Results
Effect of gestational day
Gestational day effects within cows consuming a control diet (CON, CC, and
CCC) are illustrated in Table 2. Maternal body weight and liver weight did not differ
across early-, mid-, and late-gestation. Activity of CYP1A and CYP2C were not different
across early-, mid- and late-gestation when expressed relative to mg of hepatic protein or
total hepatic enzyme activity per liver. Activity of CYP3A was decreased on day 254
versus 85 and 140 when expressed relative to mg of hepatic protein (P ≤ 0.05) while total
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CYP3A activity per liver tended (P = 0.06) to decrease on day 254 versus 85 with day
140 being intermediate. Activity of AKR1C was not different across early-, mid-, and
late-gestation when expressed as mg of hepatic protein or total hepatic enzyme activity
per liver. Activity of UGT was not different across gestational day when expressed as mg
of hepatic protein; however, total activity of UGT per liver tended (P = 0.08) to increase
on day 254 versus 85. Hepatic PPARα was increased on day 140 and 254 of gestation
versus 85 when expressed relative to mg of hepatic protein (P < 0.01). Concentrations of
E2 increased (P < 0.01) as gestation proceeded. Concentrations of P4 tended (P = 0.06) to
increase on day 254 versus 140.
Nutrient restriction from early- to mid-gestation
The effect of maternal nutrient restriction from early- to mid-gestation is
illustrated in Table 3. Gestational day by dietary treatment interactions were not observed
for the dependent variables. Therefore, main effects of maternal nutrient restriction,
independent of duration (55 d versus 110 d nutrient restriction) are discussed. Maternal
body weight and liver weight did not differ by gestational day. However, body weight
tended (P = 0.09) to be decreased and liver weight was decreased (P < 0.05) in nutrient
restricted cows versus controls. Activity of CYP1A and CYP2C were not different across
dietary treatments when expressed as mg of hepatic protein. However, total activity of
CYP1A and CYP2C per liver were decreased (P < 0.05) in nutrient restricted cows versus
controls. Activity of CYP3A, AKR1C, and UGT as well as PPARα were not different in
nutrient restricted cows versus controls when expressed as mg of hepatic protein or total
hepatic enzyme activity per liver. Concentrations of E2 were increased (P < 0.05) in
nutrient restricted cows versus controls. In contrast, concentrations of P4 were not
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different in nutrient restricted cows versus controls. Similar to the gestational day effects
observed in control cows only (Table 2), main effects of gestational day from early- to
mid-gestation were observed in PPARα (P < 0.05) and concentrations of E2 (P < 0.01).
Nutrient realimentation from mid- to late-gestation
The effect of short versus long realimentation period from mid- to late-gestation is
illustrated in Table 4. Gestational day by dietary treatment interactions were not observed
for the dependent variables. Therefore, main effects of realimentation period,
independent of gestational day are discussed. Maternal body weight tended (P = 0.06) to
be increased and liver weight was increased (P < 0.05) on gestational day 254 versus 140.
However, body weight and liver weight were not different in cows exposed to a shorter
versus longer realimentation period. Activity of CYP1A, CYP2C, CYP3A, and UGT as
well as PPARα were not different in cows exposed to a shorter versus longer
realimentation period. Activity of AKR1C was increased (P < 0.05) in cows exposed to a
longer realimentation period compared to shorter period. Concentrations of E2 were not
different in cows exposed to a shorter versus longer realimentation period. In contrast,
concentrations of P4 were decreased (P < 0.05) in cows exposed to a longer
realimentation period compared to shorter period. Similar to the gestational day effects
observed in control cows only (Table 2), a main effect of gestational day from mid- to
late-gestation was observed in concentrations of E2 (P < 0.01). In contrast to Table 2, a
main effect of gestational day was observed for activity of AKR1C, which was decreased
(P < 0.01) on day 254 versus 140 of gestation. In addition, concentrations of P4 were
increased (P < 0.01) on day 254 versus 140 of gestation.
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Correlation analysis
Hepatic activity of CYP1A, CYP2C, or UGT were not correlated with peripheral
concentrations of E2 or P4 throughout gestation. Activity of CYP3A was negatively
correlated with peripheral concentrations of E2 (r2 = -0.30; P < 0.05). Activity of AKR1C
was negatively correlated with peripheral concentrations of P4 (r2 = -0.29; P < 0.05).
Hepatic PPARα was not associated with either E2 or P4 concentrations throughout
gestation. However, PPARα was negatively correlated with both CYP1A activity (r2 = 0.30; P < 0.05) and CYP2C activity (r2 = -0.43; P < 0.01). Hepatic PPARα was not
associated with CYP3A, AKR1C, or UGT activity.
Discussion
Bovine hepatic CYP1A, CYP2C, and AKR1C activity were not different from
early-, mid- to late-gestation. In contrast, CYP3A activity decreased from mid- to lategestation, while phase II hepatic steroid metabolizing enzyme, UGT, tended to increase
from mid- to late-gestation. Therefore, exogenous and endogenous substrate metabolism
via these hepatic enzymes changes during transition into the final third of gestation.
These observations are in contrast to the previous reports in human and rodent studies. In
addition, the majority of P450 enzymes examined are down-regulated during mice
pregnancy, which was highly correlated with hepatic PPARα expression [2]. From the
current data set, PPARα was correlated with CYP1A and CYP2C activity; however, the
up-regulation of PPARα during gestation failed to down-regulate CYP1A and CYP2C
activity. The interspecies differences in P450 expression and modulation have been
previously reported, whereby substrate conjugation and metabolism varied substantially
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across pig, cattle, goat, and sheep [20]. Therefore, steroid and xenobiotic metabolism in
cattle cannot be extrapolated from previous studies in pig or rodent models.
Modifying the clearance rate of E2 could lead to an increase in placental and/or
uterine blood perfusion during specific time points of gestation. Using a similar model,
Camacho et al [21] determined that uterine artery blood flow was not different during
nutrient restriction from day 30 to 140; however, upon realimentation, uterine artery
blood flow ipsilateral to the conceptus was increased in the realimented cows versus
controls. Several mechanistic pathways are being examined with the current experimental
model; however, a portion of these responses could be related to steroid bioavailability
following extended maternal nutrient restriction. The current study highlights
concomitant changes in CYP3A activity and peripheral concentrations of E2 during
gestation. Moreover, CYP1A was decreased in nutrient restricted cows, while
concentrations of E2 were increased. The enzymes CYP1A and CYP3A are involved in
the formation of 2-OH-estradiol and 4-OH-estradiol (catechol-estrogens) metabolites,
which remain biologically active during pregnancy. Specifically, catechol-estrogens have
been implicated in vascular adaptations of the uterus throughout pregnancy including
angiogenic regulation [22]. In addition, mice showing a deficiency in these metabolites
exhibit clinical signs of preeclampsia such as hypertension and decreased angiogenesis
[22]. Thus a decrease in these P450s could result in lower concentrations of these
biologically active catechol-estrogen metabolites and in turn decrease uterine vascular
proliferation during pregnancy.
Other potential routes of E2 biotransformation exist within cattle. For example,
cellular 17β-hydroxysteroid oxidoreductase type 1 and 2 are involved in E2 metabolism
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through the interconversion of E2 to estrone. As previously discussed, E2 and estrone
serve as substrates for P450-dependent hydroxylases which then generate a series of
intermediate metabolites [22]. These metabolites will then undergo one of two possible
transformation routes, further conversion to 2- and 4-methoxy metabolites by catechol-Omethyltransferase or glucoronidation by UGTs. The 2- and 4-methoxy metabolites can
also be converted via UGTs and have been shown to have cardiovascular benefits [23].
These pathways could be beneficial during mid- to late-gestation as maternal
cardiovascular functional capacity changes dramatically to support the nutrient demands
of the exponentially growing fetus. For example, systemic arterial blood pressure and
vascular resistance decreases, while cardiac output, heart rate, stroke volume, and blood
volume increases during the last half of gestation [24].
Increasing dry matter intake has been shown to increase liver blood flow and liver
oxygen consumption in sheep [25] and increase blood flow through the hepatic portal
vein in sows [26]. Previous research has reported a significant positive relationship
between dry matter intake and liver blood flow in lactating and non-lactating dairy cattle.
The continuous high plane of nutrition in lactating dairy cattle appears to chronically
elevate liver blood flow and metabolic clearance rate of E2 and P4 [27]. Interestingly, we
observed a main effect of maternal nutrient restriction on concentrations of E2; however,
concentrations of P4 were not different during maternal nutrient restriction. Following
realimentation, concentrations of P4 were increased in cows exposed to a short period
versus long period of realimentation. From this we can speculate that a longer period of
realimentation is necessary for adaptations in liver weight, liver blood flow, or hepatic
enzymatic activity, which may regulate peripheral concentrations of P4 [27,28]. From the
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current study we can conclude that the differences in peripheral E2 and P4 following
nutrient restriction is partially modulated by the different responses in hepatic enzymatic
activity of CYP1A and AKR1C, respectively.
The hepatic transcription factor PPARα was increased during mid- and latecompared to early-gestation. Hepatic PPARs function as regulators of mammalian
metabolism with PPARα promoting fatty acid oxidation under fasting conditions.
Induction of PPARα is also speculated to decrease pro-atherosclerotic proteins and mice
lacking PPARα have prolonged inflammatory responses [29]. Additionally, a PPARα
gene knockout model in primary human hepatocytes shows a 50% decrease in CYP3A
expression [30]. In contrast, we did not observe any association with PPARα and CYP3A
activity. Although energy deprivation has been shown to activate PPARα, the current
study does not confirm this pathway in cattle. Therefore, the alterations in P450 and
AKR1C activity during nutrient restriction and/or realimentation appear to occur through
pathways independent of hepatic PPARα induction. Concentrations of E2 have also been
shown to be a potent regulator of PPARα mRNA and protein expression in rats [31].
Similarly, in cattle the steady increase in concentrations of E2 as gestation progresses
could partially explain the activation of PPARα from early- to mid-gestation. This
induction of hepatic PPARα could serve as an important energy regulator as fetal nutrient
demands are increasing, although further research is needed to corroborate this pathway
in cattle.
Conclusion
The possible implications of decreased CYP3A activity in late-gestation are
increased bioavailability of E2 and decreased formation of catechol-estrogens. Similarly,
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a concomitant decrease in CYP1A activity and increase in concentrations of E2 was
observed during maternal nutrient restriction. These alterations in hepatic modulation of
E2 metabolism could lead to differences in placental vascularity and blood perfusion
from mid- to late-gestation. Moreover, this pathway may account for abnormalities in
placental developmental capacity in compromised pregnancy models of nutrient
restriction. Activity of AKR1C decreased from mid- to late-gestation, while peripheral
concentrations of P4 increased from mid- to late-gestation. Interestingly, this late term
increase in P4 could alter placental functional capacity by increasing feto-placental
nutrient exchange during exponential growth of the fetus. Further characterization of
these enzymes may allow researchers to design specific therapeutic supplements to
modulate steroid or xenobiotic metabolism during gestation. For example, alterations in
P4 bioavailability could be used to decrease pregnancy wastage, while alterations in E2
metabolism could be used to improve placental blood perfusion.
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Table 2

CYP1A, CYP2C, CYP3A, AKR1C, and UGT activity and PPARα, E2, and
P4 concentrations in cows consuming a control diet (CON, CC, CCC) fed to
meet 100% net energy recommendations for maintenance and fetal growth
at day 85, 140, and 254 of gestation

Abbreviations: CYP1A, cytochrome P450 1A; CYP2C, cytochrome P450 2C; CYP3A,
cytochrome P450 3A; AKR1C, aldo-keto reductase 1C; UGT, uridine diphosphateglucuronosyltransferase; PPARα, peroxisome proliferator-activated receptor alpha; E2, estradiol17β; P4, progesterone; RLU, relative light units; AU, absorbance units.
a,b,c
Least square means with different letter superscripts depict differences P < 0.05.
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Table 3

CYP1A, CYP2C, CYP3A, AKR1C, and UGT activity and PPARα, E2, and P4 concentrations following a 55 d versus
110 d nutrient restriction beginning on day 30 of gestation until day 85 or day 140. The 2 × 2 factorial compared
CON, RES, CC, and RR treatment groups

Abbreviations: CYP1A, cytochrome P450 1A; CYP2C, cytochrome P450 2C; CYP3A, cytochrome P450 3A; AKR1C, aldo-keto reductase 1C;
UGT, uridine diphosphate-glucuronosyltransferase; PPARα, peroxisome proliferator-activated receptor alpha; E2, estradiol-17β; P4,
progesterone; RLU, relative light units; AU, absorbance units; Day, gestational day; Trt, nutritional plane.
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Table 4

CYP1A, CYP2C, CYP3A, AKR1C, and UGT activity and PPARα, E2, and P4 concentrations from mid (day 140) to
late (day 254) gestation following a short (RRC) versus long (RCC) realimentation period. The 2 × 2 factorial
compared RC, RR, RCC, and RRC treatment groups

Abbreviations: CYP1A, cytochrome P450 1A; CYP2C, cytochrome P450 2C; CYP3A, cytochrome P450 3A; AKR1C, aldo-keto reductase 1C;
UGT, uridine diphosphate-glucuronosyltransferase; PPARα, peroxisome proliferator-activated receptor alpha; E2, estradiol-17β; P4,
progesterone; RLU, relative light units; AU, absorbance units; Day, gestational day; Trt, duration of realimentation.
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Figure 3

Experimental design

Experimental design consisted of training 46 beef cows to the Calan gate feeding system from
day 0 to 30 of gestation [18]. On day 30 cows were randomly assigned to one of two dietary
treatments: control (CON; 100% NRC; n = 18) and nutrient restriction (RES; 60% NRC; n= 30).
On day 85 cows were slaughtered (CON, n = 6 and RES, n = 6), remained on control (CC; n =
12) and restricted (RR; n = 12) treatments, or were realimented to control (RC; n =11). On day
140 cows were slaughtered (CC, n = 6; RR, n = 6; RC, n = 5), remained on control (CCC, n = 6;
RCC, n = 5), or were realimented to control (RRC, n = 6). On day 254 all remaining cows were
slaughtered (CCC, n = 6; RCC, n = 5; RRC, n = 6).
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CHAPTER III
HEPATIC STEROID INACTIVATING ENZYMES, HEPATIC PORTAL BLOOD
FLOW, AND CORPUS LUTEUM BLOOD PERFUSION IN CATTLE

Introduction
Progesterone (P4) is required for the maintenance of pregnancy as it blocks
uterine contractions from occurring until parturition [1]. In ruminants, pregnancy wastage
may be due to decreased concentrations of P4 [2]. It is important to note that both
production from the corpus luteum (CL) and/or hepatic inactivation impacts peripheral
concentrations of P4. Size of the CL has long been used as an appropriate estimator for
luteal function due to the significant positive correlation between luteal size and P4
concentrations [3]. However, Herzog et al [4] found the use of CL blood perfusion as a
more efficient indicator of luteal function over luteal size. Rhinehart et al [5] examined
the relationship between luteal P4 secretion and liver clearance in lactating dairy cattle,
showing that liver inactivation of P4 contributed a major role in modulating peripheral P4
concentrations. Therefore, additional characterization of hepatic steroid inactivating
enzymes throughout gestation will allow researchers to design therapeutic supplements to
modify steroid clearance during critical windows of pregnancy.
Cattle with increased dry matter intake have increased blood flow through the
digestive tract and liver. This results in an increased delivery rate of steroids to the liver
and therefore increased metabolism of these substrates [6]. Excessive hepatic steroid
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inactivation contributes to decreased peripheral concentrations, which can alter
reproductive performance. In early gestation, this can lead to termination of pregnancy
and therefore diminished reproductive efficiency. During mid- to late gestation,
decreased placental nutrient exchange due to decreased concentrations of P4 can occur
[7] which can have dramatic consequences to the growth, development, and health of the
offspring in later life.
Steroids are highly lipophilic and therefore difficult for animals to excrete through
the urine and feces. However, several enzymes contribute to steroid inactivation in order
to make the steroid molecule more easily excreted. Hepatic steroid inactivation occurs in
two phases: phase I – polar groups are added to the steroid nucleus, phase II – steroid
metabolites from phase I are conjugated with glucuronic acid. These enzymes include
cytochrome P450 1A (CYP1A), 2C (CYP2C), 3A (CYP3A), aldo-keto reductase 1C
(AKR1C; Phase I), and uridine diphosphate-glucuronosyltransferase (UGT; Phase II;
[8]).
Aside from rodent characterization studies, little is known about how liver
enzyme function may contribute to reproductive performance. Hart et al [9] found that
CYP3A activity was decreased in pregnant beef cows during late-gestation and AKR1C
activity was decreased from mid- to late-gestation whereas P4 concentrations were
increased from mid- to late-gestation. However, further characterization of these enzymes
is needed throughout gestation. Therefore, our primary objective was to examine hepatic
steroid inactivating enzymes, portal blood flow, and CL blood perfusion at 10 days postinsemination in beef and dairy cows.
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Materials and methods
Animals and breeding
Animal care and use was approved by the Mississippi State University Animal
Care and Use Committee. A total of 20 early lactation Holstein cows and 20 lactating
commercial beef cows were utilized for this study. Dairy cows were managed at the Joe
Bearden Dairy Research Facility in a free stall system and fed ad libitum a total mixed
ration formulated to meet or exceed dietary requirements during early lactation. Beef
cows were managed at the H. H. Leveck Animal Research Center on 25 acres of pastures
consisting of summer forages (Bermudagrass and Dallisgrass). Cows were supplemented
with a 32% protein liquid supplement (Sup-R-Lix, Purina Animal Nutrition, Gray
Summit, MO). Estrus synchronization was performed in dairy (Ovsynch plus CIDR) and
in beef (7-day CO-Synch plus CIDR). After estrus synchronization, cows were artificially
inseminated on d 0. On d 10 post-insemination, CL blood perfusion and portal blood flow
measurements were taken via color Doppler ultrasonography, blood samples were
collected, and liver biopsies were collected. Additional blood samples were taken on d 0,
5, 15, 20, and 25 post-insemination. Pregnancy was confirmed via transrectal
ultrasonography on d 30 post-insemination. Cows were classified as either pregnant (PR;
dairy n = 7; beef n= 6) or non-pregnant (NP; dairy n = 12; beef n = 11) and data were
retrospectively analyzed as such. One beef cow and one dairy cow were removed from
the study due to lack of CL at d 10 post-insemination. Two additional beef cows were
lost due to injuries. Samples were collected from dairy cows during January 1 through 30,
2014 and from beef cows during April 24 through May 24, 2014.
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CL blood perfusion
On d 10 post-insemination, CL blood perfusion measurements were taken via
ultrasonography. The diameter of the CL was measured and CL volume was calculated
using methods previously published by Vasconcelos et al [10]. Blood perfusion was
analyzed via the power flow option of the ultrasound machine (MicroMaxx SonoSite
Inc., Bothell, WA, USA) using a transrectal ultrasound probe (5 to 10 MHz). Two to four
still images were recorded for each CL for analysis (Fig. 4). Images were uploaded from
the ultrasound machine and analyzed using ImageJ software (version 1.47, US National
Institutes of Health, Bethesda, MD, USA) to quantify total pixels of blood perfusion.
Blood perfusion is expressed as absolute perfusion and as perfusion relative to CL
volume.
Hepatic portal blood flow
On d 10 post-insemination, hepatic portal blood flow measurements were taken
via Doppler ultrasonography (MicroMaxx SonoSite Inc., Bothell, WA, USA) using a
transabdominal probe (1 to 5 MHz). Briefly, hair was removed on the right side of the
animal at the 10th intercostal space. The liver was then scanned to locate the portal vein
immediately before it divides into the left and right portal branches. The transducer was
aligned to the portal vein at an average angle of insonation of 53 ± 13 degrees (Fig. 5).
Mean velocity (MnV) was calculated using the following equation: MnV (cm/s) =
(systole – diastole) / pulsatility index. Blood flow was then calculated using the following
equation: Blood flow (mL/min) = MnV × vessel area × 60 s. Portal blood flow is
expressed as absolute portal blood flow and portal blood flow relative to kg of body
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weight. The location of major vessels within the liver was also noted in order to avoid
puncturing these vessels during the biopsy procedure.
Liver biopsy collection and processing
On d 10 post-insemination, a liver biopsy was collected. Biopsy procedures have
been previously published by Lemley et al [11]. Briefly, the area at the 10th intercostal
space, with hair having already been removed, was scrubbed three times with betadine
solution (Purdue Products L.P., Stamford, CT, USA) and approximately 10 mL of 2%
lidocaine hydrochloride (MWI, Boise, ID, USA) was administered as a local anesthetic.
After a short pause, the skin was punctured with a scalpel and approximately 1 g of liver
tissue was collected using a biopsy needle machined at Mississippi State University’s
Department of Agricultural and Biological Engineering (Mississippi State, MS; Fig. 6).
The liver sample was placed in a labeled cryogenic vial, snap-frozen in liquid nitrogen
and stored at -80°C until hepatic enzyme analyses. The incision site was closed with a
small skin staple and sprayed with antiseptic (H.W. Naylor Co., Inc., Morris, NY, USA).
Staples were removed 5 d later and cows were observed for any signs of complications or
decreased production.
Frozen liver samples were prepared according to Hart et al [9]. Briefly,
approximately 100 mg of liver tissue was weighed out, submerged in 2 mL of potassium
phosphate (KPO4) buffer (400 mM; pH = 7.4), and placed on ice for the remainder of the
procedure. Samples were then homogenized using a glass Dounce homogenizer. The
liver homogenate was centrifuged at 10,000 x g for 10 min at 4°C. The supernatant (S9
fraction) was then aliquoted into 3 separate tubes to prevent additional freeze thaw cycles
between the enzymatic activity assays. Protein concentrations in the S9 fractions were
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determined using a Coomassie Plus (Bradford) protein assay following the
manufacturer’s protocol (Thermo Scientific, Rockford, IL, USA). After determination of
protein concentration, S9 fractions were diluted in KPO4 buffer to approximately the
same concentration (~4,000 μg/mL) and were stored at -80°C. Enzyme activity is
expressed relative to liver protein (RLU/(min × mg of protein)) and relative to body
weight (RLU/(min × kg of body weight)).
Cytochrome P450 activity assays
The CYP1A, CYP2C, and CYP3A assay kits and NADPH regeneration system
were purchased from Promega Corporation (Madison, WI, USA) and prepared according
to Hart et al [9]. Following manufacturer’s instructions, reconstitution buffer was added
to luciferin detection reagent. The luciferin CEE (CYP1A), luciferin H (CYP2C), or
luciferin IPA (CYP3A) substrates were diluted in KPO4 buffer. The NADPH
regeneration system was prepared according to the manufacturer’s recommendations. In
duplicate, the S9 liver fraction and enzyme specific luciferin substrates were added to 96well opaque white plates and pre-incubated for 10 min (CYP1A and CYP3A) or 30 min
(CYP2C) at 37°C. After pre-incubation, enzyme reactions were initiated by adding the
NADPH regeneration solution to each well. The plate was incubated for an additional 30
min (CYP1A and CYP2C) at 37°C or 10 min (CYP3A) at room temperature. Following
this incubation the luciferin detection reagent was then added to each well and the plate
was protected from light and incubated at room temperature for 20 min. All plates were
then read using a Promega Multi-Plus plate reader (Madison, WI, USA) using
luminescence detection mode.
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Aldo-keto reductase 1C
Aldo-keto reductase 1C activity was determined using the methods of Lemley and
Wilson [8]. Briefly, AKR1C was determined in S9 fractions using the specific substrate,
1-acenapthenol (Pfaltz & Bauer, Waterbury, CT, USA). Enzymatic reactions contained
150 μg of cytoplasmic protein, 250 μM 1-acenapthenol, and 500 μM NADP. The 1acenapthenol dependent reduction of NADP was standardized using the amount of
cytoplasmic protein. The reduction of NADP was determined by measuring the amount
of light absorbed at 340 nm for 10 min using a Spectra Max Plus plate reader (Sunnyvale,
CA, USA). The extinction coeffeicient for NADPH (6,220 L/ mol x cm) was used to
calculate the rate of reduced NADP in pmol per min per mg of protein. In addition,
AKR1C activity is expressed per kg of body weight.
Uridine 5’-diphospho-glucuronosyltransferase
The UGT assay kit was purchased from Promega Corporation (Madison, WI,
USA). The assay was performed following the manufacturer’s recommendations with
minor modifications. It was determined that a 10 min pre-incubation resulted in an
approximate 50% disappearance of the luminogenic substrate [9], therefore the assay was
modified by decreasing the incubation time compared to the manufacturer’s
recommendations. Uridine diphosphoglucoronic acid (UDPGA) was added to half of the
wells of a 96-well opaque white plate to serve as reaction wells while double distilled
water was added to the remaining wells to serve as control wells. The UGT reaction
mixture containing UGT multienzyme substrate that is consumed by UGT1A1, 1A8,
1A9, 1A10, 2B7, and 2B15 isozymes was then added to all wells. In duplicate, the S9
liver fraction was then added to the plate. The plate was then pre-incubated for 10 min at
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37°C.The detection reagent was then added to each well and the plate was then protected
from light and incubated for 20 min at room temperature. The plate was then read using a
Promega Multi-Plus plate reader using luminescence detection mode. Activity of UGT
was calculated by following the manufacturer’s recommended formulas.
Steroid radioimmunoassay
Blood samples were collected on d 0, 5, 10, 15, 20, and 25 post-insemination via
venipuncture of the coccygeal vein into serum vacutainers (Becton, Dickinson, and
Company, Franklin Lakes NJ, USA). The P4 radioimmunoassay was performed
following manufacturer’s instructions (Siemens Healthcare Diagnostics Inc., Los
Angeles, CA, USA). Briefly, standards and unknowns were added in duplicate to the
antibody coated tubes provided with the kit. Next, 1 mL of I125 P4 tracer was added to
all tubes, covered with parafilm, vortexed, and incubated at room temperature for 3 h.
The liquid was then aspirated and discarded. The tubes were then read in a Packard
gamma counter (Meriden, CT, USA). The intra-assay coefficient of variation for the P4
assay was 6.07% for dairy and 7.08% for beef samples. The inter-assay coefficient of
variation for the P4 assay was 6.57%.
Statistical analysis
The MIXED procedure of SAS (SAS Inst. Inc., Cary, NC, USA) was used to test
the effect of gestation (PR v. NP) within each breed and to test the effect of operation
(dairy v. beef). Progesterone concentrations over time were analyzed using repeatedmeasures ANOVA of the MIXED procedure of SAS. Data found to be non-normally
distributed were tested using the Wilcoxon rank sum test. Treatment means were
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separated using the PDIFF options of the LSMEANS statement. Least square means and
SE are reported. Statistical significance was declared at P < 0.05. Tendencies declared at
P < 0.10; P > 0.05.
Results
Effects of pregnancy status within dairy and beef operations on hepatic enzyme
activity are illustrated in Table 5. Activities of CYP2C, CYP3A and AKR1C were not
different (P > 0.11) between pregnant vs non-pregnant cows when expressed per mg of
protein and per kg of body weight. Activity of CYP1A per kg of body weight tended to
be increased (P < 0.10) in pregnant vs non-pregnant dairy cows and was increased (P <
0.05) in beef vs dairy cows. Activity of CYP2C was decreased (P < 0.05) in beef vs dairy
cows with activity of CYP3A being increased (P < 0.05) in beef vs dairy cows when
expressed per mg of protein and per kg of body weight. Activity of AKR1C was also
increased (P < 0.05) in beef vs dairy cows when expressed per mg of protein. Activity of
UGT per mg of protein was not different (P > 0.53) between pregnant vs non-pregnant
cows but was increased (P < 0.05) in beef vs dairy cows. Activity of UGT per kg of body
weight was increased (P < 0.004) in pregnant vs non-pregnant dairy cows and was
increased (P < 0.05) in beef vs dairy cows. Total CL blood perfusion tended to be
increased (P < 0.10) in pregnant vs non-pregnant dairy cows and was increased (P < 0.05)
in beef vs dairy cows (Fig. 7A). Luteal volume was not different (P > 0.90) between
pregnant vs non-pregnant cows but was decreased (P < 0.05) in beef vs dairy cows (Fig.
7B). Blood perfusion relative to CL volume was not different (P > 0.50) between
pregnant vs non-pregnant cows and tended to be increased (P < 0.10) in beef vs dairy
cows (Fig. 7C). Absolute portal blood flow tended to be increased (P < 0.10) in pregnant
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vs non-pregnant dairy cows and was decreased (P < 0.05) in beef vs dairy cows (Fig.
8A). Portal blood flow per kg of body weight tended to be increased (P < 0.07) in
pregnant vs non-pregnant dairy cows and was not different (P > 0.10) between beef vs
dairy (Fig. 8B). Progesterone concentrations were not different (P > 0.10) between
pregnant vs non-pregnant or beef vs dairy cows at d 0, 5, 10 and 15 post-insemination.
However, there was a pregnancy status by day interaction (P < 0.0001), whereby P4 was
increased at d 20 and 25 post-insemination in pregnant vs non-pregnant cows (Fig. 9).
Discussion
Pregnant dairy cows tended to have increased activity of CYP1A, had increased
activity of UGT, and tended to have increased portal blood flow compared to nonpregnant dairy cows, yet no difference was found in P4 concentrations at d 10 postinsemination between pregnant vs non-pregnant dairy cows. However, pregnant dairy
cows also tended to have increased total CL blood perfusion compared to non-pregnant
dairy cows which could account for the lack of difference in P4 concentrations. Herzog et
al [12] has shown no difference in luteal blood flow area (cm2), luteal area (cm2), or P4
concentrations at d 11 post-insemination among pregnant, non-pregnant, and non-bred
dairy cows. Interestingly, there were no differences found between pregnant vs nonpregnant beef cows in any of the variables measured.
In addition to preventing parturition, progesterone also influences the secretion of
nutrients and growth factors from the uterine endometrium [13]. This enhances
embryonic development thus stimulating secretion of interferon-τ and thereby blocking
luteolysis [14]. This is another potential mechanism by which P4 maintains pregnancy in
cattle. This mechanism could explain the lack of difference in P4 concentrations in
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pregnant vs non-pregnant cows at d 10 post-insemination yet a difference beginning at d
20 post-insemination, shortly after the time of maternal recognition of pregnancy. This
exemplifies the importance of early gestation as a time to examine factors affecting the
maintenance of pregnancy in order to develop techniques to reduce pregnancy wastage.
Many operation differences were observed with activities of CYP1A, CYP3A,
AKR1C, and UGT being increased in beef vs dairy operations. Beef cows also had
increased total CL blood perfusion and increased CL blood perfusion relative to luteal
volume compared to dairy cows. Despite these differences, there was no difference in P4
concentrations between beef vs dairy cows perhaps due to the increased CL blood
perfusion in beef cows. Therefore, the potential increase in luteal P4 synthesis could be
negated by an increase in hepatic clearance leading to similar peripheral P4
concentrations.
Different management practices between these two operations may also have an
influence on the variables observed, although breed effects have been previously reported
[15]. The high plane of nutrition of lactating dairy cattle appears to elevate liver blood
flow and clearance rate of P4 [16]. Lemley et al [17] found that feeding ovariectomized
ewes a gluconeogenic diet decreased CYP2C and CYP3A activity by 45% yet had no
effect on P4 clearance. Additionally, lactating Holstein cows fed a high cornstarch,
insulin stimulating diet also had a decrease in CYP2C and CYP3A activity by 50% as
well as an increase in the half-life of P4 with no change in liver blood flow [11].
However, this is not shown in the current data set as there was no difference between
beef and dairy portal blood flow relative to body weight or P4 concentrations between
beef and dairy cows.
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Lopez et al [18] has shown that high producing dairy cattle (≥ 39.5 kg/d) had
larger pre-ovulatory follicles yet decreased concentrations of estradiol. In an
accompanying study, researchers found that high producing dairy cattle had decreased P4
concentrations despite having increased luteal volume due to double ovulation [19].
While these studies did not observe perfusion of ovarian structures, the current study is in
agreement with their results as we found decreased luteal volume in beef vs dairy cows,
yet similar concentrations of P4. We also found an increase in total CL blood perfusion as
well as CL perfusion relative to luteal volume in beef cows, suggesting that beef cows
have “more efficient” CL compare to dairy cows.
Doppler ultrasonography is a novel technique for measuring hepatic portal blood
flow. Portal blood flow values in this data set average at 603 L/h in beef and 840 L/h in
dairy with previous methods showing a range of values from 515-1,410 L/h [11, 16, 20–
27]. Previous portal blood flow measurement techniques include dye-dilution, ultrasonic
flow probes and bromosulphthalein (bromosulphthalein) infusion. Dye-dilution is
perhaps the most invasive as it involves catheterization of two-vessels, the portal vein and
an artery upstream from the portal vein. Utilizing ultrasonic flow probes is less invasive
than dye-dilution as only the vessel from which blood flow is being measured must be
catheterized. Bromosulphthalein infusion only involves catheterization of the jugular
veins and gives total liver blood flow, thus portal blood flow must be estimated. Doppler
ultrasonography is minimally invasive with no catheters involved and requires no
withdrawal period as the dye-dilution and bromosulphthalein infusions would. This
makes it a valuable technique for blood flow research and diagnostics; thus continued
validation is encouraged.
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The analysis of CL blood perfusion via Doppler ultrasonography and pixel
density analysis is another innovative technique utilized in the current study. Utilizing the
same techniques, Voelz et al [28] found that in late-lactation Holstein cows, integrated
and relative density of CL perfusion averaged to ~4,400 and ~750 pixels, respectively,
compared to our early-lactation Holstein cows integrated and relative density averages of
~8,197 and ~1,300 pixels. However, it is important to note that Voelz et al [28] reported
integrated and relative perfusion densities over the course of 10 days whereas the current
data set is only at d 10 post-insemination. This could account for the vast difference in
these measurements. They also reported luteal volume at d 10 of the estrous cycle which
was ~9 cm3. The current data set shows similar results with average luteal volume in
dairy cattle being ~8 cm3. There has been little to no research done to evaluate CL blood
perfusion in beef cattle via Doppler ultrasonography and pixel density analysis; therefore,
there is no basis of comparison for the current data set. Shirasuna et al [29] showed an
acute rise in luteal blood flow on d 17 to 18 of the estrous cycle. This increase in luteal
blood flow was accompanied by increases in mRNA expression of angiogenic factors
endothelial nitric oxide synthase, endothelin-1, and angiotensin converting enzyme. This
verifies that changes in luteal blood flow correlates with changes in angiogenic factor
expression.
The livelihood of beef and dairy production heavily relies on reproductive
success, thus continued research in this field is of the utmost importance. While hepatic
steroid inactivating enzymes have been partially characterized throughout bovine
pregnancy [9], further characterization of these enzymes throughout gestation is needed.
Future research may allow for the design of specific therapeutic supplements to modulate
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steroid metabolism during gestation. The ability to modulate these enzymes in order to
increase peripheral concentrations of progesterone could decrease pregnancy wastage and
thus increase reproductive efficiency and production.
Table 5

CYP1A, CYP2C, CYP3A, AKR1C, and UGT activity in pregnant vs nonpregnant cows at d 10 post-insemination

1

CYP1A = cytochrome P450 1A; CYP2C = cytochrome P450 2C; CYP3A = cytochrome P450
3A; AKR1C = aldo-keto reductase 1C; UGT = uridine diphosphate-glucuronosyltransferase.
2
Enzyme activity expressed relative to mg of liver protein and relative to kg of body weight.
3
Mean and SE reported.
‡
Signifies difference in dairy vs beef operation P < 0.05.
†
Signifies tendencies P < 0.10; P > 0.05.
a,b,c
Least square means with different letter superscripts depict differences P < 0.05.
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Figure 4

Corpus luteum blood perfusion via color Doppler ultrasonography

Moderate perfusion (A), minimal perfusion (B).

Figure 5

Hepatic portal blood flow

Hepatic portal blood flow via B-mode Doppler ultrasonography (A). Non-pulsatile velocity
waveforms of hepatic portal blood flow via Doppler ultrasonography (B).
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Figure 6

Biopsy needle

Machined at Mississippi State University’s Department of Agricultural and Biological
Engineering (Mississippi State, MS).
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Figure 7

Total corpus luteum blood perfusion (A), total luteal volume (B), and
relative corpus luteum blood perfusion (C)

Pregnant (PR) vs non-pregnant (NP) cows at d 10 post-insemination.
Asterisk (*) signifies differences (P < 0.05) and dagger (†) signifies tendencies (P < 0.10; P >
0.05).

70

Figure 8

Absolute hepatic portal blood flow (A) and relative hepatic portal blood
flow (B)

Pregnant (PR) vs non-pregnant (NP) cows at d 10 post-insemination.
Asterisk (*) signifies differences (P < 0.05) and dagger (†) signifies tendencies (P < 0.10; P >
0.05).
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Figure 9

Progesterone concentrations

Pregnant (PR) vs non-pregnant (NP) beef (A) and dairy (B) cows at d 0, 5, 10, 15, 20, and 25
post-insemination.
Asterisk (*) signifies differences (P < 0.05).
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